Shares in Moderna and Novavax fell in premarket trading Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some ...

On October 22, 2024, we acquired privately-held Opus Genetics Inc., a clinical-stage gene therapy company focused on IRDs, in ...

Urcosimod stable in single-use ampoules for more than 2½ years FDA requires drug to show long-term shelf stability for ...

Investing.com -- Moderna (NASDAQ: MRNA) shares dropped 13% pre-open on Monday as investors reacted to the weekend news that the U.S. Food and Drug Administration’s (FDA) top vaccine official, Dr.

In December 2024, Elicio announced the completion of enrollment of the randomized Phase 2 AMPLIFY-7P clinical trial ( ...

Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

We recently published a list of 10 AI Stocks Dominating the News This Week. In this article, we are going to take a look at ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...

Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...

We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look ...